BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 9655283)

  • 21. Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma.
    Yang R; Cheung MC; Byrne MM; Jin X; Montero AJ; Jones C; Koniaris LG
    Arch Surg; 2010 Jan; 145(1):49-56. PubMed ID: 20083754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.
    Benassai G; Mastrorilli M; Mosella F; Mosella G
    J Exp Clin Cancer Res; 1999 Mar; 18(1):23-8. PubMed ID: 10374672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic carcinoma deemed unresectable at exploration may be resected for cure: an institutional experience.
    Chao C; Hoffman JP; Ross EA; Torosian MH; Eisenberg BL
    Am Surg; 2000 Apr; 66(4):378-85; discussion 386. PubMed ID: 10776876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential and/or concurrent hypofractionated radiotherapy and concurrent chemotherapy in neoadjuvant treatment of advanced adenocarcinoma of the pancreas. Outcome and patterns of failure.
    Zimmermann FB; Schuhmacher C; Lersch C; Bernhardt B; Pickel P; Siewert JR; Molls M; Jeremic B
    Hepatogastroenterology; 2004; 51(60):1842-6. PubMed ID: 15532839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative radiation therapy and chemotherapy for adenocarcinoma of the pancreas.
    Hoffman JP; Pendurthi TK; Ross E; Yeung RS
    Hepatogastroenterology; 1998; 45(21):634-7. PubMed ID: 9684108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
    Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
    Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
    Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
    Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma.
    Farnell MB; Pearson RK; Sarr MG; DiMagno EP; Burgart LJ; Dahl TR; Foster N; Sargent DJ;
    Surgery; 2005 Oct; 138(4):618-28; discussion 628-30. PubMed ID: 16269290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer.
    Kosuge T; Kiuchi T; Mukai K; Kakizoe T;
    Jpn J Clin Oncol; 2006 Mar; 36(3):159-65. PubMed ID: 16490736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid-fractionation pre-operative chemoradiation for malignant periampullary neoplasms.
    Evans OB; Abbruzzese JL; Cleary KR; Lee JE; Buchholz DJ; Rich TA
    J R Coll Surg Edinb; 1995 Oct; 40(5):319-23. PubMed ID: 8523311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative CA 19-9 level is an important prognostic factor in patients with pancreatic adenocarcinoma treated with surgical resection and adjuvant concurrent chemoradiotherapy.
    Hallemeier CL; Botros M; Corsini MM; Haddock MG; Gunderson LL; Miller RC
    Am J Clin Oncol; 2011 Dec; 34(6):567-72. PubMed ID: 21150564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer.
    Raptis DA; Fessas C; Belasyse-Smith P; Kurzawinski TR
    Surgeon; 2010 Oct; 8(5):239-46. PubMed ID: 20709279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant therapy and survival after resection of pancreatic adenocarcinoma: a population-based analysis.
    Mayo SC; Austin DF; Sheppard BC; Mori M; Shipley DK; Billingsley KG
    Cancer; 2010 Jun; 116(12):2932-40. PubMed ID: 20336787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma.
    Lind PA; Isaksson B; Almström M; Johnsson A; Albiin N; Byström P; Permert J
    Acta Oncol; 2008; 47(3):413-20. PubMed ID: 17882555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Postoperative adjuvant radiotherapy for pancreatic carcinoma patients after radical resection].
    Lin GL; Zeng ZC; Wu Z; Jin DY; Lu WQ; Chen G; Wang J
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):308-11. PubMed ID: 19615291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
    Yeo CJ; Abrams RA; Grochow LB; Sohn TA; Ord SE; Hruban RH; Zahurak ML; Dooley WC; Coleman J; Sauter PK; Pitt HA; Lillemoe KD; Cameron JL
    Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.